Literature DB >> 7910471

Inhibitory effects of calcium antagonists on alpha-adrenoceptor-mediated contraction in the human internal mammary artery.

G W He1, T E Acuff, W H Ryan, C Q Yang, M B Douthit, R T Bowman, M J Mack.   

Abstract

1. The internal mammary artery has become a preferred coronary bypass graft. Sympathomimetic amines are spasmogens for vasospasm and calcium antagonists are frequently administered drugs perioperatively. The effect of calcium antagonists on alpha-adrenoceptor-mediated contraction depends on the subtype of alpha-adrenoceptor and the type of origin of vascular smooth muscle. This study was designed to investigate the effect of calcium antagonists on alpha-adrenoceptor-mediated contraction in the IMA. 2. Human IMA segments taken from 22 patients undergoing IMA--coronary artery bypass grafting were mounted in an organ bath under the physiological pressure determined from their own length-tension curves. 3. Three ring segments were allocated into three groups. One served as a control and the others were treated with clinically related concentrations of nifedipine (20 or 200 nM) for 25 min before concentration-contraction curves to alpha 1-adrenoceptor agonist methoxamine (MO) or full alpha-adrenoceptor agonist noradrenaline (NA) were established. 4. In separate experiments, the concentration-relaxation curves to nifedipine were established in the IMA rings precontracted with MO (30 microM) or NA (10 microM). Glyceryl trinitrate (GTN, 3 microM) was added to further relax the vessels. 5. Pretreatment with nifedipine (200 nM) only slightly inhibited the MO- (1.74 +/- 0.32 vs 2.88 +/- 0.56 g) or NA- (2.43 +/- 0.66 vs 3.60 +/- 0.82 g) induced contraction without statistical significance (P > 0.05). 6. On the other hand, nifedipine only caused 34.49% relaxation in the MO-precontracted and 24.39% relaxation in the NA-precontracted IMAs. In contrast, GTN caused 76.16% (against MO, P < 0.05) or 92.22% (against NA, P < 0.0001) relaxation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910471      PMCID: PMC1364594          DOI: 10.1111/j.1365-2125.1994.tb04257.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  33 in total

1.  Vascular smooth muscle contraction initiated by postsynaptic alpha 2-adrenoceptor activation is induced by an influx of extracellular calcium.

Authors:  J C Van Meel; A De Jonge; H O Kalkman; B Wilffert; P B Timmermans; P A Van Zwieten
Journal:  Eur J Pharmacol       Date:  1981-01-16       Impact factor: 4.432

Review 2.  Nuclear magnetic resonance--a 'magnetic eye' on metabolism.

Authors:  J R Griffiths; R A Iles
Journal:  Clin Sci (Lond)       Date:  1980-10       Impact factor: 6.124

3.  Comparison of angiotensin converting enzyme inhibitors captopril and MK421-diacid in guinea pig atria.

Authors:  A Nakashima; J A Angus; C I Johnston
Journal:  Eur J Pharmacol       Date:  1982-07-16       Impact factor: 4.432

Review 4.  New developments in Ca2+ channel antagonists.

Authors:  R A Janis; D J Triggle
Journal:  J Med Chem       Date:  1983-06       Impact factor: 7.446

5.  A comparison of coronary and internal mammary arteries and implications of the results in the etiology of arteriosclerosis.

Authors:  F H Sims
Journal:  Am Heart J       Date:  1983-04       Impact factor: 4.749

6.  Effects of nifedipine on potassium-induced contraction and noradrenaline release in cerebral and extracranial arteries from rabbit.

Authors:  E D Högestätt; K E Andersson; L Edvinsson
Journal:  Acta Physiol Scand       Date:  1982-02

7.  Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography.

Authors:  H Yasue; M Touyama; H Kato; S Tanaka; F Akiyama
Journal:  Am Heart J       Date:  1976-02       Impact factor: 4.749

Review 8.  Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem.

Authors:  P D Henry
Journal:  Am J Cardiol       Date:  1980-12-01       Impact factor: 2.778

9.  Physiological and pharmacological aspects of adrenergic receptor classification.

Authors:  E J Ariëns; A M Simonis
Journal:  Biochem Pharmacol       Date:  1983-05-15       Impact factor: 5.858

10.  Modulatory role of the vascular endothelium in the contractility of human isolated internal mammary artery.

Authors:  P Schoeffter; R Dion; T Godfraind
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

View more
  5 in total

1.  Arterial grafts: clinical classification and pharmacological management.

Authors:  Guo-Wei He
Journal:  Ann Cardiothorac Surg       Date:  2013-07

2.  Inhibition of vasoconstriction by AJ-2615, a novel calcium antagonist with alpha(1)-adrenergic receptor blocking activity in human conduit arteries used as bypass grafts.

Authors:  M H Liu; S H Floten; Q Yang; G W He
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

3.  The sources of calcium for noradrenaline-induced contraction in the human thoracic internal artery.

Authors:  Leszek Buzun; Beata Modzelewska; Anna Kostrzewska; Ewa Kleszczewska; Tomasz Kleszczewski
Journal:  Pflugers Arch       Date:  2017-04-22       Impact factor: 3.657

4.  Interaction between endothelin and vasodilators in the human internal mammary artery.

Authors:  G W He; C Q Yang; M J Mack; T E Acuff; W H Ryan; A Starr
Journal:  Br J Clin Pharmacol       Date:  1994-12       Impact factor: 4.335

5.  Potassium induced contraction of the internal thoracic artery in vitro is time related: the potential consequences in the analysis of the mechanism of the spasm after coronary artery bypass grafting and in the analysis of the results of in vitro studies.

Authors:  Tomasz Kleszczewski; Leszek Buzun; Anna Lisowska; Beata Modzelewska
Journal:  Heart Vessels       Date:  2015-05-05       Impact factor: 2.037

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.